FastPlex™ Triplex SARS-CoV-2 Detection Kits

(qPCR and Digital PCR assays for Coronavirus (COVID-19) )

PreciGenome FastPlex Triplex SARS-CoV-2 Detection Kit is a fast, highly sensitive multiplex diagnostic solution. It consists of both the assays and controls, which are needed for the real-time PCR RNA detection  from the SARS-CoV-2 virus. It is a multiplex RT-PCR diagnostic kit, enabling quick and precise diagnosis of COVID-19 caused by SARS-CoV-2 infection. 

 

FastPlex™ Triplex SARS-CoV-2 Detection Kit

(RT-PCR)

  • Detection Principle

This kit uses the 2019-Novel Coronavirus (Covid-19) ORF 1ab and the specific conserved sequence encoding the nucleocapsid protein N gene as the target regions to carry out the dual-target genes design. A one-step reverse transcription-polymerase chain reaction (RT-PCR) combined with Taqman hydrolysis probe technology was used to detect the RNAs in the sample by a fluorescence quantitative PCR instrument with changes in fluorescence signal.

The PCR detection kit includes endogenous internal standard primers and probes and monitors the sample collection and extraction process by detecting whether the internal standard is normal to avoid false-negative results.

Typical S-shape amplification curves for postive SARS-CoV-2 specimens

Amplification curves for negative SARS-CoV-2 specimens

  • Assay information

  • Kit Components

* FastPlex Triplex SARS-CoV-2 Detection Kits (RT-PCR) are sold for research use only. Not for use in diagnostic procedures.

Catalog #: 02.01.1038

  • Sample Requirements

1. Applicable sample types: upper respiratory tract samples (including throat swabs, nasal swabs, nasopharyngeal extracts, deep cough sputum); lower respiratory tract samples (including respiratory tract extracts, bronchial lavage fluid, lung tissue biopsy samples).

2. Sample collection: Collect according to the conventional sample collection method.

3. Sample storage and transportation: The collected specimens should be submitted for analysis in time, or stored at 4°C for 24 hours; it is best to store at -70°C for more than 24 hours and avoid repeated freeze-thaw cycles.

  • Documents

Instruction for User (IFU)

Performance Characteristics

 

FastPlex™ Triplex SARS-CoV-2 Detection Kit (RT-Digital PCR)

  • Detection Principle

This kit employs digital PCR technology combined with Taqman fluorescent probe, and provides qualitative detection of the 2019-Novel Coronavirus (Corvid-19).

The sample is randomly partitioned upto 25 thousand partitions, where PCR reaction is then performed. After the PCR reaction, the fluorescent signal from each partition is acquired and further analyzed based on Poisson distribution. As a result, genes specific to SARS-CoV-2 can be detected with high precision.

In particular, the Covid-19 ORF1ab probe contains FAM label, E gene probe contains HEX label, and RRP30 is used as reference gene with Cy5 label.

  • Assay information

  • Kit Components

Catalog #: 02.01.1019

* FastPlex Triplex SARS-CoV2 Detection Kits (RT-Digital PCR) are sold for Emergency Use Authorization (EUA) only. For in vitro diagnostic use.

  • Documents

FDA EUA Approved Documents: IFUFact Sheet For PatientsFact Sheet For Providers.

Related Products:

 

Swab with Transport Medium Kits  (Learn More)

Catalog #: 02.03.1003

Adapted to collection and transportation for coronavirus, virus of flu, bird flu, hand-foot and mouth disease, measles etc. It is also adapted to collection and transport for Viruses, such as Chlamydia, Mycoplasma and Ureaplasma specimens. Generally collect specimen from: Oral cavity, throat, nasopharynx, anus etc. 

  • Kit Components

Flocked swab, Virus preservation medium.

  • Documents

Manual & Instruction

 
 

COVID-19 Lab Guidance & Diagnostics

 

References

  1. (2020) 2019-Novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes. US Centers for Disease Control and Prevention.

  2. (2020) 2019 Novel Coronavirus (2019-nCoV), Wuhan, China. [Online] US Centers for Disease Control and Prevention.

  3. (2020) Real-time RT-PCR panel for detection 2019-novel coronavirus. US Centers for Disease Control and Prevention. 

  4. (2020) Emergency use authorization. [Online] US Centers for Disease Control and Prevention.

Precigenome LLC | 2176 Ringwood Ave. San Jose, CA, 95131, USA

  • LinkedIn Social Icon
  • Facebook
  • YouTube

STAY CONNECTED

© 2019 Precigenome LLC. All Rights Reserved.

Privacy Policy 

Terms of Service

Warranty, Return & Refund